G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 95 filers reported holding G1 THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25 | -51.0% | 17,480 | +84.1% | 0.00% | – |
| Q4 2022 | $51 | -100.0% | 9,496 | -51.3% | 0.00% | – |
| Q3 2022 | $243,000 | +556.8% | 19,501 | +424.8% | 0.00% | – |
| Q4 2021 | $37,000 | +117.6% | 3,716 | +374.0% | 0.00% | – |
| Q3 2021 | $17,000 | +6.2% | 784 | +7.1% | 0.00% | – |
| Q2 2021 | $16,000 | -97.1% | 732 | -96.8% | 0.00% | -100.0% |
| Q1 2021 | $554,000 | +16.4% | 23,038 | -13.1% | 0.00% | 0.0% |
| Q4 2020 | $476,000 | +47500.0% | 26,496 | +16884.6% | 0.00% | – |
| Q3 2020 | $1,000 | -85.7% | 156 | -52.0% | 0.00% | – |
| Q2 2020 | $7,000 | +40.0% | 325 | +65.0% | 0.00% | – |
| Q4 2019 | $5,000 | -80.0% | 197 | -82.2% | 0.00% | – |
| Q3 2019 | $25,000 | +1150.0% | 1,107 | +1577.3% | 0.00% | – |
| Q2 2019 | $2,000 | +100.0% | 66 | -34.0% | 0.00% | – |
| Q4 2018 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |